Drug Type Small molecule drug |
Synonyms MK 3697 |
Target |
Action antagonists |
Mechanism OX2R antagonists(Orexin receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H21N5O3S |
InChIKeyVSOUDUXMPUHJEU-UHFFFAOYSA-N |
CAS Registry1224846-01-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Initiation and Maintenance Disorders | Phase 2 | United States | - | |
Sleep Wake Disorders | Phase 2 | - | - |